Type II diabetes mellitus, mTOR (mechanistic target of rapamycin), insulin, cAMP (cyclicadenosine monophosphate) only upregulated at 78 vs. 58 in HN, glycerolipid metabolism, ErbB (erythroblastic oncogene B), arginine and proline metabolism only downregulated at 78 vs. 58 dpc in LW. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.